Literature DB >> 26923607

The Evolution and Application of Cardiac Monitoring for Occult Atrial Fibrillation in Cryptogenic Stroke and TIA.

Daniel J Miller1, Kavit Shah2, Sumul Modi3, Abhimanyu Mahajan4, Salman Zahoor5, Muhammad Affan6.   

Abstract

OPINION STATEMENT: The evaluation of the stroke and transient ischemic attack (TIA) patient has been historically predominated by the initial evaluation in the hospital setting. As the etiology of stroke has eluded us in approximately one third of all acute events, the medical community has been eager to seek the answer to this mystery. In recent years, we have seen an explosion of innovations and trends allowing for a more detailed post stroke assessment strategy aimed at the identification of occult atrial fibrillation as the etiologic cause for the cryptogenic event. This has been achieved through the evolution and aggressive application and study of prolonged and advanced cardiac monitoring. This review is aimed to clarify and elucidate the standard and novel cardiac monitoring methods that have become available for use by the medical community and expected in the higher level care of cryptogenic stroke and TIA patients. These cardiac monitoring methods and devices are as heterogeneous as our patient population and have their own advantages and disadvantages. Many factors may be taken into consideration in choosing the appropriate cardiac monitoring method and are highlighted for consideration in this review. With a judicious approach to investigating the cryptogenic stroke population, and applying a wealth of novel treatment options, we may move forward into a new era of stroke prevention.

Entities:  

Keywords:  Atrial fibrillation; Cardiac monitoring; Cryptogenic stroke; Holter; Loop recorder; Telemetry

Year:  2016        PMID: 26923607     DOI: 10.1007/s11940-016-0400-y

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  52 in total

Review 1.  Current and emerging indications for implantable cardiac monitors.

Authors:  Franco Giada; Emanuele Bertaglia; Bernhard Reimers; Donatella Noventa; Antonio Raviele
Journal:  Pacing Clin Electrophysiol       Date:  2012-04-24       Impact factor: 1.976

Review 2.  Obesity, Exercise, Obstructive Sleep Apnea, and Modifiable Atherosclerotic Cardiovascular Disease Risk Factors in Atrial Fibrillation.

Authors:  Jared D Miller; Konstantinos N Aronis; Jonathan Chrispin; Kaustubha D Patil; Joseph E Marine; Seth S Martin; Michael J Blaha; Roger S Blumenthal; Hugh Calkins
Journal:  J Am Coll Cardiol       Date:  2015-12-29       Impact factor: 24.094

3.  Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.

Authors:  Vivek Y Reddy; David Holmes; Shephal K Doshi; Petr Neuzil; Saibal Kar
Journal:  Circulation       Date:  2011-01-17       Impact factor: 29.690

4.  Prevalence and predictors of paroxysmal atrial fibrillation on Holter monitor in patients with stroke or transient ischemic attack.

Authors:  Osama Alhadramy; Thomas J Jeerakathil; Sumit R Majumdar; Emad Najjar; Jonathan Choy; Maher Saqqur
Journal:  Stroke       Date:  2010-10-14       Impact factor: 7.914

5.  Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke.

Authors:  A H Tayal; M Tian; K M Kelly; S C Jones; D G Wright; D Singh; J Jarouse; J Brillman; S Murali; R Gupta
Journal:  Neurology       Date:  2008-09-24       Impact factor: 9.910

6.  Delayed detection of atrial fibrillation after ischemic stroke.

Authors:  Hooman Kamel; Kennedy R Lees; Patrick D Lyden; Philip A Teal; Ashfaq Shuaib; Myzoon Ali; S Claiborne Johnston
Journal:  J Stroke Cerebrovasc Dis       Date:  2009 Nov-Dec       Impact factor: 2.136

7.  Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.

Authors:  David R Holmes; Saibal Kar; Matthew J Price; Brian Whisenant; Horst Sievert; Shephal K Doshi; Kenneth Huber; Vivek Y Reddy
Journal:  J Am Coll Cardiol       Date:  2014-07-08       Impact factor: 24.094

8.  Are implantable cardiac monitors the 'gold standard' for atrial fibrillation detection? A prospective randomized trial comparing atrial fibrillation monitoring using implantable cardiac monitors and DDDRP permanent pacemakers in post atrial fibrillation ablation patients.

Authors:  Steven J Podd; Conn Sugihara; Stephen S Furniss; Neil Sulke
Journal:  Europace       Date:  2015-11-18       Impact factor: 5.214

Review 9.  A review of the LARIAT device: insights from the cumulative clinical experience.

Authors:  Mukta C Srivastava; Vincent Y See; Murtaza Y Dawood; Matthew J Price
Journal:  Springerplus       Date:  2015-09-17

10.  Use of a noninvasive continuous monitoring device in the management of atrial fibrillation: a pilot study.

Authors:  Michael A Rosenberg; Michelle Samuel; Amit Thosani; Peter J Zimetbaum
Journal:  Pacing Clin Electrophysiol       Date:  2012-12-13       Impact factor: 1.976

View more
  3 in total

Review 1.  [Event recorder in cryptogenic stroke : Accepted and feasible indications].

Authors:  J Brachmann; M Held
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2016-11-14

Review 2.  Recent advances in the management of transient ischemic attacks.

Authors:  Camilo R Gomez; Michael J Schneck; Jose Biller
Journal:  F1000Res       Date:  2017-10-26

Review 3.  Recent advances in the management of transient ischemic attacks.

Authors:  Jorge Ortiz-Garcia; Camilo R Gomez; Michael J Schneck; José Biller
Journal:  Fac Rev       Date:  2022-07-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.